Universities, Research or Clinical institutes, Hospitals, or any other non-profit organisations interested into type 1 diabetes - and that share INNODIA’s objectives and values - are called to become an INNODIA Member and enter into its international network to (more than one may apply):
Contribute to accelerated and successful development of disease modifying therapies for people living with type 1 diabetes as an accredited clinical trial site or as a referral partner
Provide unique and expert opinions to interested parties
Deliver clinical grade services to run standardized or exploratory new trial outcome measures as an accredited GLP-compliant lab
Be exposed and learn to listen to the patients’ voice and include their standpoint in your decisions
Perform cutting-edge research that can be exploited by drug developers and/or investors
Be engaged and included into to a top-notch international group of experts.
INNODIA has two membership categories to choose from
| Full members | Associate members |
|---|---|
|
The category of Full Membership is open and accessible to any entity which:
|
The category of Associate Membership is open and accessible to any legal entity which:
|
|
Full Members shall enjoy all membership rights, including:
|
Associate Members shall enjoy all membership rights, including:
|
Magna ac placerat vestibulum lectus
Lorem ipsum dolor sit, adipiscing consectetur elitunc maxi musnulla ut commodo sagittis.